Post My Press Release

Free Press Release Distribution

Author: Sumaiya234 (Page 1 of 10)

Truncus Arteriosus Market is expected to grow at a CAGR of 7.8% till 2023 | by MRFR

“Global Truncus Arteriosus Market” Report of Market Research Future (MRFR)’s Explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Major Drivers, Restraints, Opportunities and Challenges.

Truncus Arteriosus Market – Overview

Truncus arteriosus is a rare congenital cardiovascular disease. In this condition, the embryological structure known as the truncus arteriosus fails to properly divide into the pulmonary trunk and aorta. Increasing prevalence of cardiovascular diseases, adoption of advanced techniques in diagnosis, and increasing government support is driving the growth of the market. According to the World Health Organization, 422 million people across the globe are suffering from diabetes. Diabetes is the major reason for cardiovascular diseases. Increasing prevalence of diabetes, rapidly developing technology, across the globe is further fuelling the growth of the market.

However, higher cost of the treatment methods may slow the growth of the market over the assessment period.

Key players:

Some of the major players in this market are Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan), AstraZeneca plc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Bayer AG, Sanofi, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Astellas Pharma, Inc., Eli Lilly and Company, Otsuka Holdings Co., Ltd., Takeda Pharmaceutical Company Limited.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/5260

Segmentation:

The global truncus arteriosus market has been segmented on the basis of types, diagnosis, treatment, and end user.

On the basis of the types, the global truncus arteriosus market is segmented into type I, type II, type III.

Based on the diagnosis, it is segmented into echocardiogram and X-ray while on the basis of treatment the market is segmented into medication, surgery, cardiac catheterization, and others.

The medication segment can be further segmented into diuretics, ionotropic agents.

On the basis of the end users, the market is segmented into hospitals & clinics, cardiac care centers, ambulatory centers & home care, academic institutes, and others.

Regional Analysis:

The Americas accounted for the major share of the market owing to the presence of a huge population suffering from heart disease, high healthcare expenditure, well-developed technology, and the presence of the leading players in the region. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the truncus arteriosus market in the Americas.

Europe accounted for the second largest market for the truncus arteriosus, which is followed by Asia Pacific. Increasing prevalence of the cardiovascular diseases, diabetes, and huge healthcare spending are the major driving factors that have boosted the market growth. Additionally, the healthcare expenditure in this region is also rising. People and healthcare organizations in this region are able to afford the high cost of the cardiovascular devices, which is further fuelling the growth of the market. Furthermore, increasing government support and funding for the development and improvement of the treatments have also contributed to the growth of the market.

Asia Pacific is the fastest growing truncus arteriosus market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.  

The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African truncus arteriosus market are increasing a number of diabetic and cardiovascular patients.

Major TOC of Truncus Arteriosus Market Research Report – Global Forecast till 2023:

  1. Report Prologue
  2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

  1. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

  1. Market Dynamics

TOC CONTINUED…

Browse Complete 100 Pages Premium Research Report Enabled with

75 Tables and Figures at https://www.marketresearchfuture.com/reports/truncus-arteriosus-market-5260

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Gel Documentation Systems Market by Worldwide Players, Top Trends, Drivers, Share, Factor Analysis and Forecast till 2023

Gel Documentation Systems Market – Overview

Global Gel Documentation Systems Market held a market value of USD 245 million in 2017 and is projected to grow at a CAGR of 3.6% over the forecast period. Gel documentation system is widely used in the molecular biology laboratories for imaging and documentation of nucleic acid and protein polyacrylamide or agarose gels.

The rising government funding’s for genomic and proteomic research, increasing prevalence of infectious diseases and genetic disorders, and the on-going technological advancements in gel documentation systems are some factors that are likely to propel the market growth during the assessment period.

According to the Centers for Disease Control and Prevention (CDC), in 2015, about 16.8 million visits to the physician’s offices were for infectious and parasitic diseases. Moreover, the increasing research and development expenditure by the government as well as private sector is expected to fuel to the market growth. Market Research Future (MRFR) announces the publication of its research report –Global Gel Documentation Systems Market, 2018-2023.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6908

On the other hand, the high cost of gel documentation systems with advanced technologies and the increasing adoption of quantitative polymerase chain reaction (QPCR) may hamper the market growth during the assessment period.

Segments:

The global gel documentation systems market has been segmented into product, detection techniques, application, and end user.

Top Players:

Some of the prominent players in the global gel documentation systems market are Bio-Techne, Endress + Hauser Management AG, GE Healthcare, Thermo Fisher Scientific, LI-COR Biosciences, Scientific Digital Imaging Plc., Cleaver Scientific, Azure Biosystems, Vilber Lourmat, and Bio-Rad Laboratories, Inc.

Currently, the global market is dominated by numerous prominent players. The key players in the market are engaged in strategic collaborations and acquisitions to strengthen their market position. For instance, in 2018, Thermo Fisher Scientific Company launched the new blue G: BOX gel documentation systems. Additionally, in February 2017, Bio-Rad laboratories, Inc. launched ChemiDoc MP Imaging System for multiplex fluorescent imaging.

Segmentation:

The global gel documentation systems market has been segmented into product, detection techniques, application, and end user.

By product, the market has been segmented into instruments, accessories, and software. The instrument segment has been further segmented into digital gel documentation instruments and film gel documentation instruments. The instruments segment is estimated to hold major market share in the global gel documentation systems market due to the rising R&D activities in the biotechnology and pharmaceutical industries.

On the basis of detection technique, the market has been segmented into ultraviolet, chemiluminescence, and fluorescence.

On the basis of application, the global gel documentation systems market has been segmented into protein quantification, nucleic acid quantification, and others.

The global gel documentation systems market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic institutes & research centers, diagnostic laboratories, and others.

Regional Analysis:

On regional basis, the Americas is anticipated to dominate the global gel documentation systems market owing to the growing clinical R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.  Europe is expected to hold the second largest position in the global gel documentation systems market owing to the presence of strong academic & research base and availability of funding for research in the European countries. The Asia-Pacific region is anticipated to be fastest growing region owing to rising government focus on biomedical and biotechnology sector and increasing number of proteomic and genomic studies in the region. The Middle East & Africa has the least share of the global gel documentation systems market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/gel-documentation-systems-market-6908

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bioimplants Market by Size, Share, Major Drivers, Topmost Players, Business Analysis and Forecast to 2023

Global “Bioimplants Market” Report is made by executing an Excellent research process to Gather information such as Bioimplants Market Growth, Eminent players, chapter-wise Description followed by various user perceptions.

Bioimplants Market – Overview

Global Bioimplants Market accounted for USD 98,350 million in 2017 and expected to register 8.6% CAGR and during the forecast period of 2018 to 2023. Bioimplants are useful for supporting, enhancing, and replacing the damaged biological structure. Bioimplants are bioengineered tissues which are compatible with human cells and helps to restore the physiological functions.

The factors propelling the growth of the global bioimplants market are the growing geriatric population, increasing number of chronic disorders, increasing demand for minimally invasive surgeries, technological advancements in healthcare sector, and rising occurrences of lifestyle disorders.

However, the high costs associated with bioimplants, rising cost of bioimplant surgeries, unfavorable reimbursement policies and dearth of technicians may hamper market growth during the assessment period.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6896

Bioimplants Market – Top Players:

Some of the key players in the global bioimplants market are Zimmer Biomet,Abbott,Boston Scientific Corporation,Dentsply Sirona,Invibio Ltd.,Integra LifeSciences,Johnson & Johnson Services, Inc.,Medtronic,Smith & Nephew plc,Stryker,Wright Medical Group N.V.,Cook Group, and C.R.Bard, Inc.

The global bioimplants market is currently dominated by several players. The market players are engaged in strategic collaborations and acquisitions to expand their product portfolios. For instance, in September 2018, DePuy Synthes(subsidiary of Johnson & Johnson Services, Inc.)  Announced acquisition of Emerging Implant Technologies (EIT) and with acquisition the company has gained access to 3D printed cellular titanium technology of EIT.

Bioimplants Market – Segments:

The global bioimplants market has been segmented on the basis of type, material, origin and end-user.

In the Americas, the North American market is likely to hold the majority share of the bioimplants market owing to the increasing prevalence of chronic diseases, rising cases of spinal cord injuries, increase in number of surgical procedures, rising lifestyle disorders and technological advancement in the region.

According to the article published by National Spinal Cord Injury Statistics Database in 2016, prevalence of spinal cord injury is increasing and approximately 54 cases per million was the ratio in US in 2016, which indicates 17,000 new cases per year in the country.

The US is expected to account for the largest share of the North American market during the forecast period owing to the presence of major market players such as Abbott, Boston Scientific Corporation , Integra LifeSciences and Johnson & Johnson Services, Inc.

Bioimplants Market – Regional Analysis:

The market in the Americas is expected to dominate the global bioimplants market during the forecast period owing to the growing geriatric population, increasing prevalence of chronic diseases, technological advancements in healthcare and rising occurrences of injuries related to spinal cord. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, increasing cardiovascular and orthopedic disorders in the region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the rising geriatric population, increasing prevalence of chronic disorders, and rising investment in healthcare sector by market players. The market in the Middle East & Africa is likely to account for the smallest share of the global bioimplants market.

Browse Complete 85 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/bioimplants-market-6896

Some Points from TOC of Global Bioimplants Market Research Report – Global Forecast till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Mobile Health Market by Revenue, Size, Growth Factors, Regional Overview and Outlook till 2023

As per the analysis of Market Research Future (MRFR), the growth of the Global Mobile Health Market is perceived to be healthy and is expected to garner high growth revenue in the coming years.

Mobile Health Market – Highlights

Global mHealth Market is projected to reach USD 21.71 billion by 2022, growing at a CAGR of 35.65% during the forecast period. Mobile health or mHealth is the practice use of mobile devices for the purpose of health services, information, and data collection. mHealth has emerged as a booming field due to advancements in the use of information and communication technology (ICT), for health services and information.

mHealth applications include the use of mobile devices such as mobile phones, tablet computers and wearable devices such as smart watches,  in collecting health data, delivery of healthcare information, real-time monitoring, and direct provision of care via mobile telemedicine.

The mHealth market is growing at an explosive pace due to the factors such as increasing awareness of mobile technology applications, surging focus on patient-centric healthcare deliver, technological innovations, concerns over the rising cost of healthcare delivery, growing integration of wireless technologies, convenience of medical devices, falling prices and growing affordability of mobile devices and others.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1816

The factors constraining the market are low mobile and network coverage in developing and poorer regions of the world, lower accuracy, poor penetration of smart devices, nascent technology in underdeveloped economies, limited reimbursement, lack of technological awareness among the ageing population, concerns over information security and privacy and others.

Mobile Health Market – Top Players:

The largest players in the mHealth market are Apple, AT&T, AirStrip, Boston Scientific, CardioNet, Athena health, Sanofi, Fitbit, Telcare, Zephyr Technology and others

However Africa remains a dark continent for the mhealth market due to its poor socio economic conditions. The countries with the least smartphone ownership rates are Tanzania (11%), Uganda (4%) and Ethiopia (4%).

Mobile Health Market – Segmentation:

mHealth Market is segmented by devices, services, technology and applications. The device segment is sub segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring, wearable fitness sensor device, heart rate meters and others. The services segment is sub segmented into diagnosis, monitoring, prevention, treatment, and others. The application segment is sub segmented into cardiovascular, respiratory, neurological, genetic diseases and others.

Mobile Health Market – Regional outlook

While mHealth grew out of industrialized nations, the field has shifted in favour of the developing countries, stemming from the rapid rise of mobile phone penetration in low-income nations. For example, in a study conducted by Pew research in contrast to a median of 45% across emerging and developing countries reported using the internet occasionally in 2013, the number in 2015, rose to a whopping 54%. The largest growth has been reported from large emerging economies such as Malaysia, Brazil and China. The comparative figures in 2015 was 87% for advanced economies such as U.S. and Canada, major Western European nations, Australia, Japan etc.

Another example can be seen in the falling divide for smartphone ownership between developing and developed economies. Smartphone ownership rates in emerging and developing nations climbed from a median of 21% in 2013 to an eye watering 37% in 2015. There also is an effect of the demographic dividend that is paying well for the market as in nearly every country, millennials are much more likely to be internet and smartphone users compared with those ages 35 and older. Other findings reveal that smartphone ownership rates have skyrocketed in many countries since 2013. This includes increases of over 25 percentage points among the economies of Turkey, Malaysia, Chile and Brazil.

In a number of emerging and developing countries, more people have access to the internet and are also using it more frequently. In 12 emerging nations surveyed in 2014 and 2015, there were significant increases in the share of adult internet users who say they access the internet several times a day, including in Nigeria (+20 points), Ghana (+19) and China (+13). Thus developing region nations are likely to be the leaders in mHealth market in the near future.

Browse Complete 301 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/mobile-health-market-1816

Major TOC of mHealth Market Research Report- Global Forecast To 2022:

1 REPORT SCOPE

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

4 INDUSTRY DYNAMICS

5 GLOBAL MHEALTH MARKET ECOSYSTEM

6 GLOBAL MHEALTHMARKET – THERAPEUTICS

7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE

8 GLOBAL MHEALTH MARKET–GEOGRAPHY

TOC CONTINUED…

LIST OF FIGURES:

FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA

FIGURE 2 XX RESEARCH METHODOLOGY

FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET

FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY

FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)

FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION)

FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION)

FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

FIGURE 9 MARKET DRIVERS AND CHALLENGES

FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

LOF COMNTINUED…!

View more Information About this Report at http://www.abnewswire.com/pressreleases/mobile-health-mhealth-market-by-size-volume-growth-factors-top-players-regional-overview-factor-analysis-and-outlook-till-2023-foretells-mrfr_311520.html

TOC CONTINUED…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Tourism Market Overview | Size, Shares, Applications, Major Vendors and Outlook till 2023

Market Research Future (MRFR)’s Released “Global Medical Tourism Market Research Report”. It contains Company information, geographical Segmentation, in-depth Table of Content, and List of figures, data tables, Various Company Leaders & market synopsis up to 2023.

Medical Tourism Market – Scenario

Market Research Future has published its newest report on the global medical tourism market which reveals an expected and promising CAGR of 21.4% during the forecast period from 2017 to 2023. Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world.

The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023. In the US, an angioplasty treatment would cost well over USD 55,000. However, in India, the cost is a fraction of the price as USD 3,300. The drastic difference in costs has led patients in developed countries with high healthcare costs to seek treatment in countries which are emerging rapidly and have a similar medical infrastructure. The reduces waiting time for treatment in these countries is also a significant factor driving growth for the global market. Timely treatment is the key to speedy recovery.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/1975

However, the prevalence of chronic diseases in some developed countries has resulted in waiting lists for treatments. These waiting lists can easily be shipped via medical tourism. Developing countries are positioning themselves as medical tourism hubs with plenty of support from local governments, thus increasing market growth. Investments in healthcare sectors of these countries have ensured high-quality treatments at comparatively low prices. Language barriers and long travel times are expected to work against market growth and challenge the global medical tourism market.

Renowned Players:

Noted market players that are included in the report are Asklepios Kliniken Verwaltungsgesellschaft mbH, Shouldice Hospital, Bangkok Hospital, Bumrungrad International Hospital, Samitivej PCL, CHRISTUS MUGUERZA, Clemenceau Medical Center, Anadolu Medical Center, Prince Court Medical Centre, Fortis Healthcare, Gleneagles Global Hospitals Group, and Schoen-Kliniken. These market players are extensively profiled in MRFR’s competitive analysis.

Medical Tourism Market – Segmentation

The global medical tourism market is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, the cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment’s growth.

Medical Tourism Market – Regional Analysis

The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, the region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period.

Latest Industry News:

  • Abu Dhabi’s Department of Culture and Tourism has just signed an MOU with the Medical Tourism Association to partner in its efforts to establish itself as a high-quality medical tourism destination
  • Cancun, Mexico, has begun development of “Health City” with the help of third-party The location of the project is situated 10 minutes from the airport and aims to increase medical tourism activities.

Major TOC of Medical Tourism Market Research Report -Forecast till 2023:

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Medical Tourism Market, By Treatment Type

7 Global Medical Tourism Market, By Region

8 Competitive Landscape

9 List of Tables

10 List of Figures

Key Questions Answered In This Report:

What will the market size and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Browse Complete 90 Pages Premium Research Report Enabled with 110 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/medical-tourism-market-1975

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

3D Cell Culture Market Analysis | Growth Overview, Size, Shares, Application and Outlook till 2023

Market Research Future Introduces the “Global 3D Cell Culture Market” Research Report. Reports Provides the classifications and industry Structure with Top Industry Players, Recent Trends and Industry Dynamics up to 2023.

3D Cell Culture Market – Overview

3D Cell culture is a technique in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Besides, the ability of 3D cell culture to provide more physiologically relevant information and more accurate data in vivo tests has led 3D cell culture systems to become acceptable in comparison to 2D Cell culture. The Global 3D Cell Culture Market Is Expected To Grow At A CAGR Of 25.50% During The Forecast Period 2018–2023.

Many factors drive the market of 3D cell culture across the world such as an advanced technique in organ and tissue regeneration, provide drug toxicology screening and many more.

The global 3D cell culture market has been identified as one of the fastest growing industries, owing to the varying applications of 3D cell culture in biotech and pharmaceutical industry and rising prevalence of cancer worldwide, rising approval from government bodies, and growing awareness Increasing incidence of cancer and rising demand for organs transplantation due to increasing prevalence of organ failures has majorly influenced the growth of the market.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/5928

3D Cell Culture Market – Segmentation:

The global 3D cell culture market has been segmented into the application, end user, product, technique, and lastly region. Based on application, this market has been segmented into cancer research, drug discovery, regenerative medicine, stem cell research, tissue screening & engineering, and others. Drug discovery is the process that helps the researchers to discover new candidate medications. Regenerative medicine is defined as a branch of translational research in molecular biology and tissue engineering. It deals with the process to replace, engineer or regenerate human cells, tissues or organs in order to restore or establish normal function. The process of borrowing cells from developed organs of the body and used for repairing unhealthy organs is called stem cell research. The purpose of tissue engineering is to assemble the functional constructs that heel, maintain and restore the damaged tissues or whole organs.

On the basis of end users, the global 3D cell culture market has been segmented into contract research organizations, pharmaceutical & biotechnology companies, research & academic laboratories and others. Contract research organizations provide support to the biotechnology, medical device, and pharmaceutical industries in the form of research services outsourced on a contract basis. Based on products, the market has been segmented into consumables and instruments. Consumables include products like vials, cotton buds, cleaning materials, plastic funnels, etc. Instruments include devices that are used for surgeries and activities like removing the tumor. On the basis of technology, the market has been segmented into scaffolds based 3D cell culture and scaffold-free 3D cell culture. To develop the field of tissue engineering in order to regenerate damaged tissues, the cells from the body are combined with highly porous scaffold biomaterials that act as templates for tissue regeneration and guides the growth of new tissue. A technique based on scaffold biomaterials is called scaffolds based on 3D cell culture. Scaffold-free methods include the use of hanging drop plates, low adhesion plates, magnetic 3D bioprinting, magnetic levitation, micropatterned surfaces, and rotating bioreactors.

Latest Industry News:

  • ALPCO, a leading producer of research and clinical immunoassays, has announced its partnership with InSphero, AG. This partnership aims to provide customers with a complete solution to assess beta-cell function in islet micro tissue culture models. 24 JUL 2018
  • Collaborating with the University of Strathclyde, Biotechnology giant AMSBIO has set up a new joint venture company called ScreenIn3D, exploiting the latest advances in microfluidics and 3D cell culture, to develop a novel microfluidic screening platform. 6 JUL 2018.

3D Cell Culture Market – Key Players:

The key players in the global 3D cell culture market include Becton-Dickinson and Company (USA), Charles River Laboratories Inc (USA), Corning Incorporated (USA), The Electrospinning Company (UK), InSphero, AG (Switzerland), Kuraray Co Ltd (Japan), Lonza (Switzerland), Lena Biosciences Inc. (USA), Merck KGaA (Germany), Tecan Trading AG (Switzerland), ReproCELL Europe Ltd (UK), and Thermo Fisher Scientific Inc. (USA).

3D Cell Culture Market – Regional Overview

The regional segmentation of the global 3D cell culture market covers The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). With many key players based in the United States of America (USA) and due to the availability of advanced technology, North America is a bigger market than South America. In the USA, maximum organ transplant surgeries have taken place since 2016. In Europe, due to reasons same as North America, being more advanced technologically, Western Europe is a bigger market than Eastern Europe.

In the Asia Pacific region, some countries like Japan and Singapore are technologically advanced. And in countries like India and China, the technological advancement is taking place at a slow but steady pace. This is primarily due to less expenditure (compared to governments in Western countries) from governments on medical healthcare. Other countries of Asia Pacific that are strong markets for 3D cell culture include Australia and South Korea, followed by rest of Asia Pacific countries. In the MEA countries, the market is small due to lack of technological advancement, less priority from the government to healthcare and lawless environment due to events like Arab Spring. Some countries in this region do have a decent amount of technological advancement and doctors with modern education because of which, they can be suitable markets for 3D cell culture. Such countries are Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by rest of MEA region.

Major TOC of 3D Cell Culture Market Research Report – Forecast to 2023:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global 3D Cell Culture Market, By Technique

7 Global 3D Cell Culture Market, By Product

TOC CONTINUED…

Browse Complete 100 Pages Premium Research Report Enabled with 200+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

EMEA Blood Coagulants Market Analysis | Size, Share, Growth Overview and Outlook till 2023

Market Research Future (MRFR)’s study reveals that the “EMEA Blood Coagulants Market”, and it is projected to thrive exponentially striking a CAGR of 9.5% up to 2023.

Blood Coagulants Market- Scenario

The market is expected to grow at the CAGR of 9.5% during the forecast period 2017-2023 Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.

The Middle East & Africa blood coagulant market growth is majorly attributed to increasing prevalence of the bleeding disorders, rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/2743

In the Middle East and Sub-Saharan Africa, bleeding disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.

As per the study published in Blood Coagulation Fibrinolysis journal, 2016, it is reported that in the Yaoundé Hemophilia Treatment Center (HTC) of Cameroon multiple cases of hemophilia and von willebrand disease (VWD) have been registered According to the 2014 Annual Global Survey of World Federation of Hemophilia (WFH), in 2014 the total population of Egypt was 86,895,099 out of which 5,246 people were living with hemophilia, 513 were living with von willebrand disease, and 1,123 with other bleeding disorders.

It is also reported that 4201 cases of hemophilia A were registered and among them 37% were under 4 years A  research study published in Medicine journal in 2017 stated that hemophilia A is the most common type of hemophilia in Saudi Arabia and most dominant in male patients: 1 : 5000 to 10,000. Whereas, prevalence rate of hemophilia B: 1: 34,500 male patients.

The Middle East & Africa blood coagulant market growth is majorly attributed to increasing prevalence of the bleeding disorders, rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders. On the other hand, there are certain factors that also hinder the growth of this market such as lack of R&D capabilities in the regions, presence of counterfeit drugs, and lack of awareness in most of the parts of developing and underdeveloped countries in the region.

Blood Coagulants Market – Segmentation

The MEA blood coagulants market is segmented on the basis of types, indications, and by country.

On the basis of types, the market is segmented into coagulation factor and others. Coagulation factor is further segmented into recombinant coagulation factor, plasma coagulation factor, and others.

On the basis of indication, the market is segmented into haemophilia, surgery, other bleeding disorders, and others. Haemophilia is further divided into haemophilia A and haemophilia B.

On the basis of country, the market is segmented into KSA, UAE, Qatar, Oman, Kuwait, Egypt, and Rest of Middle East & Africa. 

Blood Coagulants Market – Prominent Players:

Pfizer

Bayer

Novo Nordisk

Shire

SOBI

And Others.

Blood Coagulants Market – Regional Analysis

The Middle East & Africa blood coagulants market is segmented on the basis of countries into Saudi Arabia (KSA), United Arab Emirates (UAE), Qatar, Oman, Kuwait, Egypt, and rest of Middle East & Africa. Saudi Arabia account for the largest market share of the Middle East & Africa blood coagulants market by countries in 2016. The large share is majorly attributed to increasing prevalence of the haemophilia disease in this country, high usage of the expensive recombinant coagulation factors for the treatment, and high disposable income of the population, and better healthcare facilities in this country.

Key Findings:

  • Hemophilia segment dominates the market with nearly 45.5% share of the MEA market
  • MEA coagulation factor market is projected to reach about USD 141.68 million by 2023
  • MEA blood coagulants market for hemophilia segment was estimated to be USD 31.55 million in 2016
  • UAE is the fastest growing region in the MEA blood coagulants market with 10.1% CAGR during 2017 to 2023

Major TOC of Blood Coagulants Market – Middle East & Africa forecast till 2023:

1 Report Prologue

2 Research Methodology

3 Market Dynamics

4 Middle East & Africa Blood Coagulants Market by Type

5 Middle East & Africa Blood Coagulants Market, By Indication

6 Middle East & Africa Blood Coagulants Market, By Country

7 Company Profiles

8 List of Tables

9 List of Figures

Browse Complete 53 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/blood-coagulants-market-2743

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Catheters Market Analysis | Growth Overview, Regional Analysis, Size, Share, Application and Forecast till 2023

Market Research Future (MRFR)’s study reveals that the “Global Catheters Market”, the report offer detailed Analysis about the Top Trends and Current Scenario with competitive landscape and key regions development status.

Catheters Market – Overview

The Global Catheters Market is expected to grow at a CAGR of 6.14% during the forecast period 2017-2023. Catheters, a thin tube like medical devices inserted into a body cavity, duct, or vessel.

They are used in drainage, administration of fluids or gases, and also to perform a wide variety of other tasks depending on the type of catheter. Increasing prevalence of the patients cardiac and urological diseases have increased the demand for the catheters. To increase the market demand, many manufacturers are trying to introduce the new and advanced types of catheters.

The global catheter market is majorly driven by increasing prevalence of cardiac & urological diseases, increasing preference for minimal invasive therapy, and increasing geriatric population. Additionally, changing lifestyle and rising healthcare spending have spurred the growth of the market. However, long time for approval, and risk of infection may slow the growth of the market over the review period.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/3186

Competitive Players:

Boston Scientific Corporation

Koninklijke Philips N.V

Abbott

Medtronic plc

Braun Melsungen AG

Becton

Dickinson and Company.

Segmentation:

The global catheters market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, neurological catheters, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. 

Regional Analysis:

The Americas dominate the global market owing to a huge population with cardiac diseases, increasing geriatric population, strong government support for research & development and high health care spending.

According to the WHO, in 2014, 9.7% of total America population had diabetes. Increasing prevalence of the diabetes has boosted the market growth in America. Additionally, changing lifestyle and the presence of major players in the market have fueled the growth of the market.

Europe is the second leading region in the global catheters market, which is followed by Asia Pacific. Asia Pacific is the fastest growing catheters market majorly driven by India, China, and Japan owing to a huge number of patients and rapidly growing economy. The healthcare expenditure in in Asia Pacific has increased during last few years, which has contributed to the growth of market.

The Middle East and Africa contribute the least to the growth of the global market. The UAE, Saudi Arabia, and Kuwait lead the Middle East & Africa market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. However, the growth of the African market is high due to the presence of opportunities for the development of the market.

Major TOC of Catheters Market Research Report – Global Forecast till 2023:

1  Report Prologue

2  Market Introduction

3  Research Methodology

4  Market Dynamics

5  Market Factor Analysis

6  Global Catheters Market by Type

7  Global Catheter Market by End User

8  Global Catheters Market by Region

9  Company Landscape

10  Company Profiles

11  List of Tables

12  List of Figures

Browse Complete 83 Pages Premium Research Report Enabled with 89 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/catheters-market-3186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Page 1 of 10

Powered by WordPress & Theme by Anders Norén